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Probiotics due to their multifaceted health promoting attributes have gained immense research impetus in recent years. 
The current study reports the hypocholesterolemic potential of lactic acid bacteria (LAB) isolated from indigenous sources. 
LAB may use several mechanisms for lowering serum cholesterol level viz. cholesterol assimilation, bile salt deconjugation, 
and cholesterol adsorption on cell surface of live, resting and dead probiotic cells. Cholesterol lowering is generally a strain 
dependent phenomenon, and different LAB isolates exhibited varying level of hypocholesterolemic effects. Among the LAB 
isolates, K2 i.e. Enterococcus faecalis K2 showed the highest in vitro cholesterol lowering ability (82.32%), and strong bile 
salt deconjugation potential, and released about 128.43 µM/mL of cholic acid upon bile salt deconjugation. Furthermore, 
cholesterol removal by live, resting and dead E. faecalis K2 probiotic cells was shown to the extent of 72.46, 44.93, and 
45.88%, respectively. Scanning electron microscopy displayed appreciable adherence of cholesterol on to the cellular 
surfaces of E. faecalis K2 cells. The antioxidant potential of the cell free cultural fluid of LAB isolates was quite variable. 
LAB isolate E. faecalis K2 showed appreciable DPPH radical scavenging activity (37.36%), hydroxyl radical scavenging 
ability (26.35%), and superoxide radical scavenging ability (42.67%). Most of the LAB probiotic isolates were susceptible 
to conventionally used antibiotics, and lacked biogenic amine producing ability and haemolytic activity. The probiotic 
isolate E. faecalis K2 may have potential for application for management of hypercholesterolemia related coronary heart 
diseases, however, after thorough in vivo investigation.  
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Multifaceted health-promoting effects of probiotics 
have attracted a great deal of research attention in 
recent years
1
. As the health benefits of probiotics 
exhibit huge variations, bioprospecting of new/novel 
strains of efficacious probiotics (lactic acid bacteria, 
LAB and others) has always been an ongoing 
practice
2
. Cholesterol lowering potential is considered 
as one of the most imperative functional attribute of 
probiotics
3
. Raised serum cholesterol level poses high 
risk for cardiovascular diseases (CVDs), obesity and 
other metabolic disorders
4
. Recently CVDs have 
become one of the major causes of mortality
5
. 
Considering the adverse effects of therapeutic 
approaches of cholesterol lowering, application of 
probiotics for managing raised cholesterol levels, and 
hence the CVDs has gained immense research 
impetus
6,7
. Antioxidant potential is another important 
health promoting feature of probiotics
8
.
 
Safety 
analysis of probiotics is absolutely essential prior to 
their commercilization
9
. In the current study the 
hypocholesterolemic potential of LAB probiotic 
isolated from several sources including an 
indigenously milk fermented product kalarei
10
 was 
examined by bile salt hydrolysis, bile salt 
deconjugation, and cholesterol assimilation. 
Furthermore, probiotic isolates were studied for 
antioxidant activity and biosafety properties. 
 
Materials and Methods 
Probiotics strains, culture medium, and growth conditions 
Five probiotic LAB isolates F11, F17 (from faeces 
of healthy infants), M16, M17 (human breast milk), 
and K2 (local fermented milk product, kalarei) were 
procured from culture collection of Fermentation 
Biotechnology Laboratory,, School of Biotechnology, 
University of Jammu, Jammu
11
. These LAB isolates 
have previously been characterized for several of the 
probiotic functional attributes
11
. Each culture was 
activated from stock cultures maintained in 20% 
glycerol (−80°C). Bacterial cells were propagated in 
De Man-Rogosa-Sharpe (MRS) broth by incubating at 
37°C for18 h.  
The probiotic isolates were examined for 
cholesterol lowering, and antioxidant potential, and 
—————— 
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biosafety aspects. The isolate (K2) which exhibited 
most of the desired attributes was identified based on 
16S rDNA sequence analysis
1
. Universal primer  
pair used for PCR amplification was lac1-27F  
5-AGAGTTTGATCCTGGCTCAG and lac1-1492R 5-
TACGGYTACCTTGTTACGACT). PCR-amplification 
was executed and the amplicon was sequenced  
and analyzed.  
 
Cholesterol assimilation ability of the LAB isolates  
Cholesterol was dissolved in 50% ethanol  
(5 mg/mL), filter sterilized and added to MRS-broth 
supplemented with 0·3% ox-bile at a final 
concentration of 100 µg/mL. The MRS medium was 
inoculated with (1%, v/v) overnight grown probiotic 
culture (10
8
-10
10
 cfu/mL) and incubated anaerobically 
at 37C for 18 h. The culture was centrifuged  
(10000 × g at 4°C for 10 min) to get the cell free 
supernatant (CFS). CFS was examined for the 
remaining cholesterol concentration
12
. For analysis of 
cholesterol 1.0 mL aliquot of CFS was mixed with  
1.0 mL of KOH (33%, w/v) and 2.0 mL of absolute 
ethanol. The contents were well mixed and allowed to 
stand at 37C for 15 min. Then 2.0 mL of distilled 
water and 3.0 mL of hexane were added and mixed 
well. One mL of top hexane layer was transferred into 
a glass tube and evaporated under nitrogen 
atmosphere. The residue was immediately dissolved 
in 2.0 mL of o-phthalaldehyde reagent and mixed 
well. Then 0.5 mL of concentrated H2SO4 was added, 
and the content was mixed and incubated at room 
temperature for 10 min. Finally, the absorbance was 
read at 550 nm. The amount of cholesterol lowered 
was determined by subtracting the amount of 
cholesterol in each sample (µg/mL) from the amount 
present in the uninoculated control.  
 
Bile salt deconjugation assay for the LAB isolates  
Bile salt deconjugation ability was measured
6
 by 
inoculating MRS-broth supplemented with 6 mM 
sodium glycocholate with overnight grown culture 
(10
8
-10
10
 cfu/mL) at (1% v/v) and by incubating 
anaerobically at 37C for 18 h. Then 10 mL of the 
culture was adjusted to pH 7·0 with NaOH (1.0 M) 
and centrifuged at 10000 × g at 4°C for 10 min, and 
the pH of the supernatant, thus, obtained was adjusted 
to 1.0 with HCl (1.0 M). Bile salt deconjugation assay 
was set up by adding 1.0 mL of the supernatant into 
2.0 mL of ethyl acetate followed by vortexing for  
1 min. Then 2.0 mL of the top ethyl acetate layer was 
transferred into a glass tube and evaporated under 
nitrogen atmosphere at 60C. The residue was 
immediately dissolved in 1.0 mL of NaOH (0·01 M). 
After complete mixing, 1.0 mL of furfuraldehyde 
(1%) and 1.0 mL of H2SO4 (8.0 M) were added, and 
the mixture was vortexed for 1 min before heating at 
65C in a water-bath for 10 min. After cooling,  
2.0 mL of glacial acetic acid was added, and the 
mixture was mixed well, and read for absorbance at 
660 nm. The amount of cholic acid released from 
deconjugation of bile salts was determined from the 
cholic acid standard curve. 
 
Cholesterol removing potential of growing, dead and resting 
cells probiotic cells  
Comparative cholesterol lowering potential of 
growing, dead and resting cells was studied
13
. For 
growing cell assay, overnight grown cells were 
inoculated (1%, v/v) in MRS broth supplemented with 
0.1 g/L of cholesterol and 0.5% (w/v) sodium 
glycocholate and the cultures were incubated 
anaerobically at 37C for 18 h. Similarly, for resting 
cell assay, MRS broth was inoculated with test 
cultures (1%, v/v) and incubated anaerobically at 37°C 
for 18 h. Then, contents were centrifuged at 5000 × g 
for 5 min and the cell pellet was washed with sterile 
saline. The cell pellet was suspended in 0.05 M 
phosphate buffer (pH 6.8) containing 0.5% oxgall,  
0.1 g/L of cholesterol and 0.5% (w/v) sodium 
glycocholate. For dead cell assay, the cells were 
grown in MRS broth for 18 h and then cells were 
harvested and re-suspended in phosphate buffer saline 
(pH 7.0) and heat-killed at 100C for 15 min followed 
by centrifugation (5000 × g for 5 min). The heat killed 
cells were resuspended in 0.05 M phosphate buffer 
(pH 6.8) containing 0.1 g/L of water soluble 
cholesterol and 0.5% (w/v) sodium glycocholate. The 
test strains were incubated at 37C for 24 h and then 
the mixture was centrifuged (10000 × g for 5 min at 
4C) and the CFS was used for cholesterol assay.  
In all the three setups, the remaining cholesterol 
concentration (µg/mL) was determined from CFS 
using the method described by Rudel and Morris
14
.  
 
SEM analysis for adsorption of cholesterol to probiotic cell 
surface 
Cholesterol adsorption by the cell surface of 
growing, and dead probiotic cells was studied using 
scanning electron microscopy (SEM). Growing and 
dead cells were prepared
13
. In the assay three sets of 
cells were studied i.e. (1) cells grown in MRS broth 
supplemented with cholesterol only, (2) cell grown in 
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MRS broth supplemented with cholesterol and bile 
salt, and (3) heat killed cells suspended in 0.05 M 
phosphate buffer (pH 6.8) containing cholesterol. The 
cells grown in MRS broth without any 
supplementation were used as a control. Cholesterol 
attached to the cell surfaces (three conditions and 
control) was observed using scanning electron 
microscopy (Electron Microscope, JEOL JEM -
100CXII, CSIR-IIIM, Jammu). Probiotic cells were 
fixed in 2.5% (v/v) glutaraldehyde (pH 7.4) for 2 h at 
4C. The bacterial cells were washed with 0.1 M of 
phosphate buffer saline and centrifuged at 5000 rpm 
for 10 min. Cell pellet was fixed for 1.0 h in 1.0% 
osmium tetraoxide prepared in phosphate buffer. The 
sample was washed two times with distilled water for 
10 min and centrifuged. After proper processing, the 
probiotic cells were coated with gold and viewed 
under scanning electron microscope and images were 
taken at 5000 and 10000x.  
 
Antioxidant potential of LAB isolates 
The 2, 2-diphenyl-1-picrylhydrazyl (DPPH) free 
radical scavenging capacity of CFS of each probiotic 
culture (10
8
-10
10
 cfu/mL) was determined
15
. Briefly, 
1.0 mL of CFS was added to 2.0 mL ethanolic DPPH 
radical solution (0.05 mM) and the mixture was 
mixed vigorously and incubated at room temperature 
in the dark for 30 min. The blank contained only 
ethanol and the cells. The control included deionized 
water and DPPH solution. Ascorbic acid was taken as 
positive control. Absorbance of the resulting solution 
was measured at 517 nm. The scavenging ability was 
expressed as: 
 
100
controlA
blankAsampleA
1(%)activityScavenging 

  
 
Hydroxyl radical scavenging assay was conducted 
by a Fenton reaction method
15
. Briefly, the reaction 
mixture containing 2.0 mL of FeSO4 (0.5 mM),  
1.0 mL of brilliant green (0.435 mM), 1.5 mL of  
H2O2 (3.0%, w/v), and 1.0 mL of CFS was incubated  
at room temperature for 20 min, and then the 
absorbance was measured at 624 nm. The absorbance 
change of the reaction mixture indicated the 
scavenging ability of the probiotic strains for 
hydroxyl radicals. Hydroxyl radical scavenging 
activity is expressed as: 
 
100
A0)(A
A0)(As
1(%)activityScavenging 


  
Where, as the absorbance in the presence of the 
sample, A0 is the absorbance of the control in the 
absence of the sample, and A is the absorbance 
without the sample and Fenton reaction system. 
The superoxide radical scavenging activity of CFS 
of probiotic cells was determined
16
. The superoxide 
radical was generated in 3.0 mL of 0.1 M sodium 
phosphate buffer (pH 7.4) containing 156 µM  
β-nicotinamide adenine dinucleotide (NADH), 52 µM 
nitroblue tetrazolium (NBT) and 20 µM phenazine 
methosulfate (PMS). After addition of 1.0 mL CFS, 
the reaction mixture was incubated at 25C for 5 min. 
The scavenging activity of superoxide radical was 
expressed as: 
 
100
blankA
sampleA
1(%)activityScavenging   
 
Deionized water and ascorbic acid (Vc) were used 
as the blank and positive control, respectively. 
 
In vitro biosafety evaluation LAB probiotic isolates 
Blood hemolysis test for probiotics LAB was done. 
Fresh bacterial cultures were streaked on agar plates 
containing 5% (v/v) calf blood. The plates were 
incubated at 37°C for 48 h under anaerobic condition 
and the plates examined for signs of β-haemolysis 
(clear zones around colonies), α-haemolysis (green-
hued zones around colonies) or γ-haemolysis  
(no zones around colonies)
17
. 
Gelatin hydrolyzing activity of probiotics LAB was 
done by analyzing their gelatinase producing ability 
on TND-gelatin agar (1.7% tryptone, 0.3%  
neo-peptone, 0.25% dextrose, 0.5% NaCl, 0.25% 
K2HPO4 and 1.5% agar, 0.4% gelatin). LAB cultures 
were spotted on TND-gelatin agar plates and 
incubated at 37°C for 3 days. Then the plates were 
flooded with saturated ammonium sulfate solution. 
Appearance of clear zones around the inoculated 
culture spots against the opaque background indicates 
gelatinase producing ability.  
Biogenic amines production by LAB probiotics 
was examined on the decarboxylation medium
18
. The 
LAB isolates were grown in MRS broth containing 
0.1% (w/v) amino acids (tyrosine and histidine) and 
0.005% pyridoxal phosphate to promote the enzyme 
induction, for 4 days at 37°C. Visual observation of 
the cultures was made after end of incubation. Change 
in the coloration of culture from yellow to violet is an 
indicative of decarboxylase positive reaction.  
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Antibiotic susceptibility of five probiotic cultures 
was assessed by employing disk diffusion method
19
. 
Ten conventionally prescribed antibiotics used were 
Penicillin-G (P), Gentamycin (GEN), Vancomycin 
(VA), Erythromycin (E), Ampicillin (AMP), 
Chloramphenicol (C), Fusidic acid (FC), Clindamycin 
(CD) and Kanamycin (K), Tetracycline (TE). Details 
of respective concentration, group and mode of action 
of antibiotics is given in (Table 1).  
 
Results and Discussion 
The current study was conducted to investigate the 
in vitro cholesterol lowering potential of probiotic 
lactic acid bacteria isolated
20
 from local fermented 
milk products kalarei (isolate K2), infant feces  
(F11, F17) and human breast milk (M16, M17). These 
LAB isolates have previously been characterized for 
various probiotic functional attributes like excellent 
adhesion, coaggregation and autoaggregation, 
antimicrobial potential, and exopolysaccharide 
producing ability
11,20
. Exopolysaccharides were 
isolated and characterized from probiotic bacterium 
Enterococcus faecium K1 isolated from fermented 
indigenous milk product kalarei
20
. In the current 
study, cholesterol lowering potential of these 
probiotic LAB was evaluated based on bile salt 
hydrolase (BSH) activity, bile salt deconjugation 
ability and the cholesterol assimilation potential. The 
cell surface change of probiotic bacteria in presence 
of cholesterol and bile salts was also studied using 
scanning electron microscopy (SEM). Furthermore, 
the probiotic isolates were also studied for their 
antioxidant potential, and bio-safety analysis.  
 
Cholesterol assimilation ability of the LAB isolates 
The LAB isolates were able to remove cholesterol 
from MRS-broth supplemented with ox-bile (0.3%) 
and cholesterol (100 µg/mL) during growth. The  
LAB isolate K2 showed the highest in vitro cholesterol  
 
lowering ability of 82.32% followed by isolate M17, 
F11, and M16 which displayed cholesterol lowering 
ability of 53.41, 41.09, and 31.05%, respectively, 
after 24 h of incubation (Fig. 1A). The isolate F18, 
however, exhibited meagre cholesterol lowering 
potential (13.65%). Similar to current study, a 
probiotic isolate Lactobacillus reuteri LR6 showed 
Table 1 — Antibiotics used for Antibiotic susceptibility assay of LAB probiotic isolates 
Antibiotic Amount in the disc (µg) Group of antibiotic Mode of action 
Penicillin-G (P) 10 µg β-Lactams Cell wall synthesis inhibitors 
Gentamycin (GEN) 10 µg Aminoglycosides Protein synthesis inhibitors 
Vancomycin (VA) 30 µg Glycopeptides Cell wall synthesis inhibitors 
Erythromycin (E) 15 µg Macrolides Cell wall synthesis inhibitors 
Ampicillin (AMP) 10 µg β-Lactams Cell wall synthesis inhibitors 
Chloramphenicol (C) 30 µg Others Protein synthesis inhibitors 
Fusidic acid (FC) 10 µg Fusidane Protein synthesis inhibitors 
Clindamycin (CD) 2 µg Lincosamide Protein synthesis inhibitors 
Kanamycin (K) 10 µg Aminoglycoside Protein synthesis inhibitors 
Tetracycline (TE) 30 µg Tetracyclines Protein synthesis inhibitors 
 
 
Fig. 1 — Cholesterol lowering by probiotic isolates based upon 
cholesterol assimilation (A), Bile salt deconjugation  
(B); Cholesterol removal by live; and (C) dead and resting cells  
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cholesterol lowering
21 
by 68.19±0.86%, whereas 
Lactobacillus pentosus KF923750 did remove 
cholesterol by 62.4% after 24 h of incubation
22
. 
Cholesterol assimilation by probiotic bacteria in the 
gastrointestinal tract allows the reduced absorption of 
cholesterol by enterocytes, and more excretion of the 
cholesterol from the host, thus, lowering the serum 
cholesterol level, and potentially resulting in decreased 
risk of cardiovascular diseases
23
. Thus, cholesterol 
reduction by probiotic bacteria via assimilation, 
enzymatic degradation and/or other mechanisms may 
help managing hypercholesterolemia related CVDs. In 
this study probiotic isolate K2 exhibited significant 
cholesterol lowering activity in vitro indicating its 
potential for pharmacological applications.  
 
Bile salt deconjugation potential of LAB isolates 
Bile salt deconjugation mechanism is based on the 
ability of certain probiotics to enzymatically 
deconjugate bile acids, and there upon increasing  
their rates of excretion via feces
24
. Since, cholesterol 
being a precursor of bile acids, deconjugation 
enhances the conversion of cholesterol to bile acids 
replacing those lost during excretion, and thus 
resulting in lowering of the serum cholesterol level
24
.
 
All the LAB probiotic isolates caused substantial 
reduction of bile salt and exhibited strong 
deconjugation activity when grown in MRS broth 
supplemented with bile salt sodium glycocholate. The 
probiotic isolate K2 deconjugated sodium 
glycocholate maximally and released an amount of 
128.43 µM/mL of cholic acid after 24 h. Probiotic 
isolates M16, M17, F11 and F18 also exhibited 
considerable bile salt deconjugation activity and 
released 106.69, 101.47, 98.65 and 77.34 µM/mL of 
cholic acid, respectively (Fig. 1B). Lactobacillus 
fermentum CAT19 and L. fermentum CABA16 were 
reported to show bile salt deconjugation ability of 
sodium glycocholate, and released free cholic acid in 
the range of 0.12 to 0.40 µM/mL
24
. In general, bile 
salt deconjugation is species and strain dependent 
phenomenon which may explicate the variations in 
deconjugation ability of various strains.  
 
Cholesterol lowering by live, dead and resting probiotic cells  
The living, dead, and resting probiotic cells were 
examined for their cholesterol lowering potential. 
Among living cells, isolate K2 exhibited highest 
hypocholesterolemic ability of 72.46%, followed by 
isolate F11 (60.05%) after incubation of 24 h. Among 
dead cells, isolate K2, and F18 showed almost similar 
cholesterol lowering ability of 45.88 and 42.24%, 
respectively (Fig 1C). Cholesterol removal by dead 
cells might be attributed to cell surface adhesion of 
cholesterol by probiotic cells. Among resting cells 
(live but non-dividing), isolate F11 showed highest 
cholesterol lowering ability of 44.93, followed by 
isolate M16 (41.43%). Choi and Chang
13
 found that 
living cells of Lactobacillus plantarum EM showed 
cholesterol removing ability of 88.12%. Miremadi  
et al.
25
 observed that growing, resting and dead cells 
removed cholesterol in range of 34-65%, 29-56% and 
9-37%, respectively. The cholesterol removal by 
resting and dead probiotic cells confirmed that their 
cellular membrane still had the ability to adhere to the 
cholesterol. Results indicated that cholesterol 
lowering phenomenon is not only displayed by living 
cells involving assimilation mechanism, but also by 
an adhesion mechanism (non-metabolic process) to 
cell surfaces of dead and resting cells
13,25
. Current 
study shows that maximum cholesterol lowering  
was exhibited by live and growing cells of probiotic 
LAB isolate K2, however, the resting and dead 
counterparts also displayed significant cholesterol 
lowering which suggests that the non-viable cells of 
the probiotics may also explored as potential 
cholesterol lowering agents. 
 
SEM analysis for cell surface adsorption of cholesterol by 
probiotics  
SEM analysis was performed to examine the 
adherence of cholesterol to probiotic cell surface, 
which is assumed to be a possible mechanism for 
cholesterol lowering. SEM analysis was executed for 
LAB isolate K2 grown in MRS broth without 
cholesterol Control (Fig. 2A), with cholesterol only 
(Fig. 2B), and with cholesterol and bile salt (Fig. 2C). 
Also SEM analysis was carried out for heat killed 
cells which were suspended in MRS broth containing 
cholesterol to determine the surface adsorption of 
cholesterol by heat killed cells (Fig. 2D). The results 
of SEM analysis of live and dead cells would give 
insights about the differences (if any) between the 
adhesion mechanisms employed by live and dead 
probiotic cells. The surface adhesion properties of 
probiotics represent important mechanism for 
cholesterol removal
13
.  
Probiotic isolate K2 clearly showed strong 
cholesterol binding capability to its cell surface when 
compared with control (Fig. 2B), thus, indicating its 
potential effectiveness for reducing the serum 
cholesterol level
13
. Similar cholesterol binding affinity 
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was shown by probiotic strain K2 in MRS medium 
supplemented with bile salt (Fig. 2C). The cholesterol 
binding abilities can be attributed to chemical and 
structural properties of cell wall peptidoglycans 
containing amino acids that might have capability of 
binding to the cholesterol
26
. SEM micrograph of heat 
killed probiotic K2 cells also showed strong cholesterol 
binding affinity to cell surfaces (Fig. 2D). Similar 
results were shown by Lactobacillus plantarum EM 
and L. acidophilus ATCC 43121 where both probiotic 
strains showed cholesterol adhesion to cell membrane 
in dead state
13
. Cholesterol adherence was found to the 
surface of lactobacilli and the attachment of cholesterol 
was hypothesised to be dependent on growth
26
. 
Adherence of cholesterol to bacterial cell surface is a 
physical phenomenon that might be affected by cell 
wall polymers containing protein moieties which are 
able to bind cholesterol. This feature indicates that 
probiotic microorganisms both in their live, dead and 
attenuated forms may have potential application for 
lowering down the cholesterol level.  
 
Antioxidant activity potential of LAB isolates 
In the current study, antioxidant activity of LAB 
probiotic isolates was determined by DPPH radical, 
hydroxyl radical and superoxide radical scavenging 
potential. The isolate F18 showed the highest DPPH 
radical scavenging ability of 53.02% followed by 
M17 (42.93%), F11 (37.99%) and K2 (37.36%)  
(Fig. 3A). Similar to current study, Lactobacillus 
rhamnosus R4 displayed 53.78% DPPH scavenging 
ability
27
. All tested probiotic strains exhibited 
appreciable scavenging activities against cellular toxic 
substance like DPPH radicals to various degrees, 
indicating their detoxifying effects. Probiotics possess 
antioxidant enzymatic systems and one of the best 
known of these enzymes is superoxide dismutase 
(SOD) which catalyzes the breakdown of superoxide 
into hydrogen peroxide and water and is therefore, a 
central regulator of reactive oxygen species (ROS) 
levels. Additionally, probiotics produce other 
metabolites with antioxidant activity, such as 
glutathione (GSH), butyrate, and folate which help in 
neutralization of ROS
8
. Strong DPPH radical 
scavenging activity of probiotic bacteria indicates 
 
 
Fig. 2 — SEM analysis of cell surface adsorption based 
cholesterol removal by Enterococcus faecalis K2 (10000×);  
(A) Cells grown in MRS broth; (B) Control, cells grown in MRS 
supplemented with cholesterol; (C) Cells grown in MRS 
supplemented with cholesterol and bile salt; and (D) Heat killed 
cells suspended in phosphate buffer  
 
 
Fig. 3 — (A) Antioxidant activity potential of probiotic LAB 
isolates based upon DPPH free radical scavenging activity;  
(B) Hydroxyl radical scavenging activity; and (C) Superoxide 
radical scavenging activity  
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their high antioxidant potential. Though oxidation is 
important for energy generation in the living 
organisms, but oxidative stress can lead to severe 
damage to the biomolecules of vital importance for 
various physiological and metabolic functions. 
Antioxidative properties of probiotics thus, may  
play an important role in combating the drastic  
effects of ROS.  
Antioxidant potential based upon hydroxyl radical 
scavenging activity was also studied for LAB isolates. 
The reactive free radicals induce oxidative damage to 
biomolecules, and results in manifestation of cancer 
and several other diseases
15
. In the current 
investigation, LAB isolate M17 showed the highest 
hydroxyl radical scavenging ability of 51.88%  
(Fig. 3B) followed by M16 (30.12%), K2 (26.35%) 
and F18 (23.43%). The isolate F11 showed lowest 
scavenging ability of 20.08% Similar results were 
observed for Lactobacillus rhamnosus R4 which 
displayed hydroxyl scavenging ability
27
of 45.79%. 
Similarly, intracellular cell-free extracts of the 11  
L. plantarum strains demonstrated hydroxyl radical 
scavenging activity in a dose-dependent manner 
within the cell concentration range of  
10
8
-10
10
 cfu/mL
15
. Hydrogen peroxide is a weak 
oxidant, but it is extremely diffusible and has longer 
half life. These two properties of hydrogen peroxide 
lead to the oxidative damage either directly or due to 
formation of hydroxyl radicals on reaction with 
transition metal ions. Significant hydroxyl scavenging 
activity of probiotic isolates shows their adequate 
antioxidative potential.  
Antioxidant potential of the LAB isolates was also 
examined by superoxide radical scavenging activity. 
The LAB isolate K2 showed the highest superoxide 
radical scavenging ability of 42.67% (Fig 3C) 
followed by F18 (40.46%), M17 (39.09%), and F11 
(35.73%). Similar to current study, Lactobacillus 
plantarum MA2 displayed superoxide radical 
scavenging ability
28
 of 40.22 ± 0.03%. Reactive 
oxygen species such as superoxide anion is produced 
during cellular metabolism and plays an important 
role in cell signalling, apoptosis, gene expression and 
ion transportation. However, when such ROS 
molecules are generated in excess or cellular defences 
are deficient, biomolecules including protein, lipid, 
and nucleic acids get damaged due to oxidative stress. 
Such damage may lead to a variety of age-related 
degenerative diseases, such as cancer, Alzheimer’s 
disease, and Parkinson’s disease15. Superoxide 
dismutase scavenges superoxide anions which are 
precursors of hydrogen peroxide, hydroxyl radical, 
and singlet oxygen which might induce oxidative 
damage to lipids proteins and DNA.  
 
In vitro biosafety evaluation of LAB probiotic isolates. 
Safety evaluation of probiotics is absolutely 
essential to ensure their usage for various health 
benefits for human beings. All the five LAB probiotic 
isolates were evaluated for their safety aspects viz., 
blood hemolysis, gelatin hydrolysis and biogenic 
amines production.  
Hemolytic test analysis of the LAB isolates i.e. K2, 
M16, M17, F11 and F18 on blood (bovine) agar 
plates, showed that none of the probiotic isolates 
showed α- or β- hemolytic activity (Table 2).  
For safety concern, it is desired that probiotics should 
not exhibit haemolysis. Similarly, Lactobacillus 
fermentum strains did not show β-haemolytic activity, 
however, L. fermentum 0-25A and L. fermentum  
12-18A strains showed α-haemolytic activity17.  
In view of the fact that none of the tested  
strains showed blood hemolysis so these may  
be considered biologically safe, and may be  
further explored for other functional aspects and 
application potential. 
Gelatin hydrolysis ability of the probiotic isolates 
(K2, M16, M17, F11, and F18) is determined by their 
ability to produce gelatinase (proteolytic enzyme) that 
liquefies the gelatin. Two of the probiotic isolates i.e. 
M17 and F18 hydrolyzed the gelatin as indicated by 
appearance of hydrolytic zones on gelatin agar plates. 
However, isolate K2, M16 and F11 did not show  
any gelatin hydrolysis on gelatin agar plates.  
 
Table 2 — Biosafety analysis of LAB probiotic isolates based upon hemolysis, gelatin hydrolysis and biogenic amines production 
Probiotic LAB isolates Hemolysis pattern   
Growth Zone Hemolysis Gelatin hydrolysis  Biogenic amines 
K2 - - - - - 
M16 - - - + - 
M17 - - - + - 
F11 - - - - - 
F18 - - - + - 
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Ramesh et al.
29
 observed that KADR5 and KADR6 
strains of Bacillus sp. isolated from the gut of  
Labeo rohita showed considerable gelanotilytic activity.  
Biogenic amines production assay was done for 
LAB isolates. Several toxic conditions and food 
poisoning cases among human are associated with 
histamine and tyramine amines. Secondary amines 
may undergo nitrosation and form nitrosamines
30
. 
Therefore, the probiotic isolates were studied for their 
ability to produce biogenic amines using 
decarboxylation medium containing tyrosine and 
histidine. The results indicated that no biogenic amine 
like tyramine and histamine was produced by any of 
the probiotic LAB isolates. Similar to current study, 
none of seven strains tested for histidine, lysine, 
ornithine, and tyrosine, showed any of the  
amine production
9
. However, Lactobacillus casei 
(TISTR 389) and Lactobacillus delbrueckii subsp. 
bulgaricus (TISTR 895) produced biogenic amines 
histamine and tyramine
31
. Therefore, careful screening 
for biogenic amines production is recommended before 
selecting probiotics for appropriate application in food, 
dairy and pharmaceutical industry.  
All the LAB isolates were examined for their 
antibiotic susceptibility. Antibiotic susceptibility is 
one of the essential functional characteristic of 
potential probiotics, and probiotics intended for 
human/animal application must not possess any 
antibiotic resistance against commonly used 
antibiotics
32
.
 
Most of the LAB probiotic isolates 
showed susceptibility towards ten conventionally 
prescribed antibiotics (Table 3). However, strain K2, 
M16, and F11 showed moderate resistance towards 
vancomycin which might be due to interference of 
vancomycin
33
 in cell wall peptidoglycan synthesis. 
Similarly, Lactobacillus strains isolated from 
pharmaceutical and dairy products were highly 
resistant to vancomycin and streptomycin
34
. 
Molecular identification of LAB isolate equipped with the 
most desired characteristics  
The LAB probiotic isolate K2 from kalarei 
exhibited ample hypocholesterolemic potential, 
antioxidant activity and safety attributes, thus, was 
selected for its identification by 16S rDNA sequence 
analysis. The 16S rDNA sequence of LAB isolate K2 
showed close resemblance (97%) with that of several 
of Enterococcus faecalis strains available in GenBank 
database (National Centre for Biotechnology 
Information, NCBI). Therefore, the strain was 
designated as Enterococcus faecalis K2. The  
sequence was deposited in GenBank under the 
accession number MG754449.  
 
Conclusion 
The current study was carried out to study the 
cholesterol lowering potential of LAB probiotic 
isolates from indigenous sources. Several of the 
isolates exhibited hypocholesterolemic and 
antioxidant potential, and qualified for the bio-safety 
aspects. The probiotic strain Enterococcus faecalis K2 
was found to be the most potential cholesterol 
lowering strain that also possessed other functional 
attributes. The cholesterol lowering by probiotic  
E. faecalis K2 was mediated by several mechanisms 
like assimilation, bile salt deconjugation, and cells 
surface adhesion. Even the dead cells showed 
sufficient cholesterol removing ability. However,  
for harnessing full biotechnological potential of  
E. faecalis K2 in food/feed and pharmaceutical 
industry, further in vivo studies must be executed for 
cholesterol lowering activity and other functional 
attributes.  
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